BNS Stock Bank of Nova Scotia (BNS, $73.72) was a top quarterly gainer, rising +15.04%

GET DAILY SIGNALS

Get AI intraday signals

BNS - Bank of Nova Scotia

Loading...

Price: $73.72

Daily change: +$0.71 (+0.97%)

Daily volume: 1.6M

3-month price change: +$9.64 (+15.04%)

Capitalization: $90.8B

Industry: Major Banks

Bank of Nova Scotia (BNS, $73.72) was one of top quarterly gainers, jumping +1 to $73.72 per share. A.I.dvisor analyzed 61 stocks in the Major Banks Industry over the last three months, and discovered that of them () charted an Uptrend while none of them () trended down.

BNS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BNS turned positive on December 24, 2025. Looking at past instances where BNS's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 25, 2025. You may want to consider a long position or call options on BNS as a result. In of 67 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNS advanced for three days, in of 335 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 330 cases where BNS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNS broke above its upper Bollinger Band on December 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 26, placing this stock slightly worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.629) is normal, around the industry mean (1.419). P/E Ratio (17.882) is within average values for comparable stocks, (13.073). Projected Growth (PEG Ratio) (1.638) is also within normal values, averaging (4.378). Dividend Yield (0.042) settles around the average of (0.040) among similar stocks. P/S Ratio (3.411) is also within normal values, averaging (3.621).